Two-dimensional speckle tracking echocardiography demonstrates no effect of active acromegaly on left ventricular strain
- 195 Downloads
Speckle tracking echocardiography (STE) allows for the study of myocardial strain (ε), a marker of early and subclinical ventricular systolic dysfunction. Cardiac disease may be present in patients with acromegaly; however, STE has never been used to evaluate these patients.
To evaluate left ventricular (LV) global longitudinal strain in patients with active acromegaly with normal LV systolic function.
Cross-sectional clinical study.
Patients with active acromegaly with no detectable heart disease and a control group were matched for age, gender, arterial hypertension and diabetes mellitus underwent STE. Global LV longitudinal ε (GLS), left ventricular mass index (LVMi), left ventricular ejection fraction (LVEF) and relative wall thickness (RWT) were obtained via two-dimensional (2D) echocardiography using STE.
Thirty-seven patients with active acromegaly (mean age 45.6 ± 13.8; 48.6% were males) and 48 controls were included. The mean GLS was not significantly different between the acromegaly group and the control group (in %, −20.1 ± 3.1 vs. −19.4 ± 2.2, p = 0.256). Mean LVMi was increased in the acromegaly group (in g/m2, 101.6 ± 27.1 vs. 73.2 ± 18.6, p < 0.01). There was a negative correlation between LVMi and GLS (r = −0.39, p = 0.01).
Acromegaly patients, despite presenting with a higher LVMi when analyzed by 2D echocardiography, did not present with impairment in the strain when compared to a control group; this finding indicates a low chance of evolution to systolic dysfunction and agrees with recent studies that show a lower frequency of cardiac disease in these patients.
KeywordsAcromegaly Left ventricular strain Speckle tracking echocardiography Cardiopathy
The research has not received funding from any organization or company and was sponsored by the authors themselves.
Compliance with ethical standards
Conflict of interest
MRG has received unrestricted research grants and lecture fees from Novartis, Ipsen and Pfizer, has participated on advisory boards of Novartis and Ionis, and is a principal investigator in clinical trials by Novartis and Ipsen. The other authors have no conflicts of interest.
All procedures performed were in accordance with the ethical standards of the HUCFF/UFRJ ethical committee and with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.
- 5.Hurchard H (1895) Anatomie pathologique lesions et troubles cardiovasculares de l’acromegalie. J Prat 9:249–251Google Scholar
- 12.Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Della Morte AM, Pivonello R, Salvatore M, Lombardi G (2001) Is the acromegalic cardiomyopathy reversible? Effect of 5-Year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. J Clin Endocrinol Metab 86:1551–1557PubMedGoogle Scholar
- 14.Mann DL, Zipes DP, Libby P, Bonow RO (2015) Braunwald’s heart disease: a textbook of cardiovascular medicine. 4th edn. Elservier, AmsterdamGoogle Scholar
- 15.Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP (2010) Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr 23:351–369, quiz 453–355CrossRefGoogle Scholar
- 16.de Almeida AL, Gjesdal O, Mewton N, Choi EY, Teixido-Tura G, Yoneyama K, Lima JA (2013) Speckle-Tracking pela Ecocardiografia Bidimensional – Aplicações Clínicas. Revista Brasileira Ecocardiogr imagem cardiovasc 26:38–49Google Scholar
- 18.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Jama. 289:2560–2572CrossRefPubMedGoogle Scholar
- 20.Lang, RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group, American Society of Echocardiography’ Guidelines and Standards Commiitee, European Association of Echocardiography (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 18:1440–1463CrossRefPubMedGoogle Scholar
- 21.Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39.e14CrossRefPubMedGoogle Scholar
- 25.Cheng S, Larson MG, McCabe EL, Osypiuk E, Lehman BT, Stanchev P, Aragam J, Benjamin EJ, Solomon SD, Vasan RS (2013) Age- and sex-based reference limits and clinical correlates of myocardial strain and synchrony: the Framingham Heart Study. Circ Cardiovasc Imaging 6:692–699CrossRefPubMedGoogle Scholar
- 26.dos Santos Silva CM, Gottlieb I, Volschan I, Kasuki L, Warszawski L, Balarini Lima GA, Xavier SS, Pedrosa RC, Neto LV, Gadelha MR (2015) Low frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort. J Clin Endocrinol Metab 100:4447–4455CrossRefPubMedGoogle Scholar
- 28.Mignot A, Donal E, Zaroui A, Reant P, Salem A, Hamon C, Monzy S, Roudaut R, Habib G, Lafitte S (2010) Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study. J Am Soc Echocardiogr 23:1019–1024CrossRefPubMedGoogle Scholar
- 29.Ersboll M, Valeur N, Andersen MJ, Mogensen UM, Vinther M, Svendsen JH, Moller JE, Kisslo J, Velazquez EJ, Hassager C, Sogaard P, Kober L (2013) Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction. JACC Cardiovasc Imaging 6:851–860CrossRefPubMedGoogle Scholar
- 30.Almeida AL, Silva VA, Souza Filho AT, Rios VG, Lopes JR, Afonseca SO, Cunha DD, Mendes MO, Miranda DL, Júnior S (2015) Disfunção Ventricular Subclínica Detectada por Speckle Tracking Dois Anos após Uso de Antraciclina. Arq Bras Cardiologia 104:274–283Google Scholar
- 33.Galderisi M, Vitale G, Bianco A, Pivonello R, Lombardi G, Divitiis O, Colao A (2006) Pulsed tissue Doppler identifies subclinical myocardial biventricular dysfunction in active acromegaly. Clin Endocrinol 64:390–397Google Scholar
- 34.Bogazzi F, Di Bello V, Palagi C, Donne MG, Di Cori A, Gavioli S, Talini E, Cosci C, Sardella C, Brogioni S, Mariani M, Martino E (2005) Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study. Clin Endocrinol 62:590–596CrossRefGoogle Scholar
- 35.Edvardsen T, Gerber BL, Garot J, Bluemke DA, Lima JA, Smiseth OA (2002) Quantitative assessment of intrinsic regional myocardial deformation by Doppler strain rate echocardiography in humans: validation against three-dimensional tagged magnetic resonance imaging. Circulation 106:50–56CrossRefPubMedGoogle Scholar
- 36.Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, Støylen A, Ihlen H, Lima JA, Smiseth OA, Slørdahl SA (2006) Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol 47:789–793CrossRefPubMedGoogle Scholar
- 39.Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, Petretta M, Tamburrano G, Lombardi G, Liuzzi A (2000) Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 85:193–199PubMedGoogle Scholar
- 52.Imanishi R, Ashizawa N, Ohtsuru A, Seto S, Akiyama-Uchida Y, Kawano H, Kuroda H, Nakashima M, Saenko VA, Yamashita S, Yano K (2004) GH suppresses TGF-beta-mediated fibrosis and retains cardiac diastolic function. Mol Cell. Endocrinol 218:137–146Google Scholar
- 53.Bogazzi F, Lombardi M, Strata E, Aquaro G, Di Bello V, Cosci C, Sardella C, Talini E, Martino E (2008) High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients with untreated active acromegaly: an in vivo study using magnetic resonance imaging. Clin Endocrinol 68:361–368CrossRefGoogle Scholar
- 57.Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L, Pivonello R, Grottoli S, Losa M, Cannavo S, Minuto F, Montini M, Bondanelli M, De Menis E, Martini C, Angeletti G, Velardo A, Peri A, Faustini-Fustini M, Tita P, Pigliaru F, Borretta G, Scaroni C, Bazzoni N, Bianchi A, Appetecchia M, Cavagnini F, Lombardi G, Ghigo E, Beck-Peccoz P, Colao A, Terzolo M, Italian Study Group of Acromegaly (2012) Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol 167:189–198PubMedGoogle Scholar